Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5

Hezhen Wang, Bader Huwaimel, Kshitij Verma, James Miller, Todd M. Germain, Nihar Kinarivala, Dimitri Pappas, Paul S. Brookes, Paul C. Trippier

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Mitochondrial complex II (CII) is an emerging target for numerous human diseases. Sixteen analogues of the CII inhibitor natural product atpenin A5 were prepared to evaluate the structure–activity relationship of the C5 pyridine side chain. The side chain ketone moiety was determined to be pharmacophoric, engendering a bioactive conformation. One analogue, 1-(2,4-dihydroxy-5,6-dimethoxypyridin-3-yl)hexan-1-one (16 c), was found to have a CII IC50 value of 64 nm, to retain selectivity for CII over mitochondrial complex I (>156-fold), and to possess a ligand-lipophilicity efficiency (LLE) of 5.62, desirable metrics for a lead compound. This derivative and other highly potent CII inhibitors show potent and selective anti-proliferative activity in multiple human prostate cancer cell lines under both normoxia and hypoxia, acting to inhibit mitochondrial electron transport.

Original languageEnglish (US)
Pages (from-to)1033-1044
Number of pages12
JournalChemMedChem
Volume12
Issue number13
DOIs
StatePublished - 2017

Keywords

  • anticancer agents
  • atpenin A5
  • mitochondria
  • mitochondrial complex II
  • succinate dehydrogenase

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5'. Together they form a unique fingerprint.

  • Cite this

    Wang, H., Huwaimel, B., Verma, K., Miller, J., Germain, T. M., Kinarivala, N., Pappas, D., Brookes, P. S., & Trippier, P. C. (2017). Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5. ChemMedChem, 12(13), 1033-1044. https://doi.org/10.1002/cmdc.201700196